US2007128126A1PendingUtilityA1
Airway Alkalinization as Therapy for Airway Diseases
Est. expiryJan 14, 2020(expired)· nominal 20-yr term from priority
A61K 31/553A61K 31/198A61K 31/573A61K 31/35A61K 31/19A61K 45/06A61K 31/40A61K 33/02A61K 31/58A61K 31/56A61K 9/0078A61K 31/135A61K 31/137A61K 31/7088A61K 31/55A61K 38/063
69
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a method of treating asthma by raising the pH of the airways of an individual. The effect can be mediated directly by administering a pharmaceutically acceptable basic solution or alternatively, the effect can be mediated by enhancing the activity of glutaminase.
Claims
exact text as granted — not AI-modified1 - 41 . (canceled)
42 . A method for enhancing the therapeutic efficacy of inhaled S-nitrosoglutathione (GSNO) used in the treatment of asthma and other airway diseases of a patient comprising
combining at least one non-toxic, alkaline composition, selected from the group consisting of acetate salts, ammonium salts, phosphate salts, bicarbonate salts, glycine and glutamine together with a basic buffer having an alkaline pKa, and administering the combination in an aerosol form to the airways of a patient.
43 . The method of claim 42 wherein the combination is administered simultaneously with the inhaled GSNO.
44 . The method of claim 42 wherein the combination is administered prior to treatment with the inhaled GSNO.
45 . The method of claim 42 wherein the combination has a pH in the airways of a patient which is either acidic or alkaline.
46 . The method of claim 45 wherein the combination has a pH of between approximately 6.0 and approximately 10.0.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.